Fernando Valenzuela, Carle Paul, Lotus Mallbris
Jun 7, 2016
Citations
1
Influential Citations
43
Citations
Quality indicators
Journal
Journal of the European Academy of Dermatology and Venereology
Abstract
Tofacitinib is an oral Janus kinase inhibitor that is being investigated for psoriasis. Psoriasis impacts on physical and psychological well‐being; improvements in health‐related quality of life (HRQoL) with etanercept in psoriasis are well documented.